Pharmacy Benefit Managers: Who are they?

Pharmacy Benefits Managers (PBMs) play a pivotal role in the U.S. healthcare system, functioning as intermediaries between insurers, pharmaceutical companies, and pharmacies. They have a significant influence on the prescription drug market, impacting costs, accessibility, and the overall management of pharmacy benefits. This blog post explores the role of PBMs, their impact on healthcare costs, the benefits and criticisms associated with them, and potential future trends.

Understanding Pharmacy Benefits Managers (PBMs)

Pharmacy Benefits Managers originated in the 1960s, with their role expanding significantly as prescription drug use and healthcare costs rose. At their core, PBMs are companies that manage prescription drug benefits on behalf of health insurers, Medicare Part D drug plans, large employers, and other payers. They aim to negotiate lower prices for prescription drugs, design formularies (lists of covered drugs), and manage the network of pharmacies available to beneficiaries.

How PBMs Impact Healthcare Costs

One of the primary roles of PBMs is to negotiate prices with drug manufacturers. They do this by promising to include certain drugs in their formularies in exchange for discounts or rebates. This negotiation process can lead to lower drug prices for insurance plans and their beneficiaries. However, the opacity of these negotiations and the question of whether savings are passed on to consumers remain subjects of debate.

PBMs also manage pharmacy networks, determining which pharmacies will be included and the reimbursement rates for prescription drugs. This can affect where patients can fill their prescriptions and how much pharmacies are paid, impacting both convenience and the financial health of pharmacies.

Benefits and Criticisms of PBMs


  • Cost Savings: By negotiating drug prices, PBMs can potentially lower the cost of prescription drugs for payers and patients.
  • Access and Convenience: PBMs manage extensive pharmacy networks, improving access for patients and offering mail-order pharmacy services, which can increase convenience and adherence to medication.
  • Clinical Management Programs: Many PBMs offer programs aimed at improving medication adherence, managing chronic conditions, and optimizing medication use.


  • Lack of Transparency: The negotiations and contracts between PBMs, drug manufacturers, and pharmacies are often confidential, leading to questions about where the savings go and whether they are passed on to consumers.
  • Impact on Small Pharmacies: The reimbursement rates set by PBMs can put financial pressure on independent and small pharmacies, potentially affecting their viability.
  • Potential for Conflicts of Interest: Some PBMs are owned by or have affiliations with health insurers and pharmacies, raising concerns about conflicts of interest and the impartiality of their drug formularies and pharmacy networks.

The Future of PBMs

The landscape for PBMs is changing, driven by regulatory scrutiny, public pressure for more transparency, and the evolving healthcare market. There’s a push for regulations that would require PBMs to disclose more information about their negotiations and the rebates they receive. Additionally, the integration of healthcare services, where PBMs, insurers, and providers are under the same umbrella, may reshape how PBMs operate, potentially aligning incentives more closely with patient care and cost savings.

In conclusion, Pharmacy Benefits Managers are a crucial component of the U.S. healthcare system, playing a complex role in managing prescription drug costs and access. While they offer potential benefits in terms of cost savings and management of drug benefits, they also face criticism regarding transparency and their impact on pharmacies. As the healthcare landscape continues to evolve, the role of PBMs and how they operate will likely undergo significant changes, hopefully leading to a more transparent and effective system that benefits all stakeholders, especially patients.

Scroll to Top